These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9595220)

  • 1. Importance of alpha 1-sympathetic activity for diurnal change in ischemic threshold in patients with stable angina.
    Fujita M; Tanaka T; Nakae I; Tamaki S; Kihara Y; Nohara R; Sasayama S
    Clin Cardiol; 1998 May; 21(5):357-61. PubMed ID: 9595220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade.
    Dunselman PH; van Kempen LH; Bouwens LH; Holwerda KJ; Herweijer AH; Bernink PJ
    Am J Cardiol; 1998 Jan; 81(2):128-32. PubMed ID: 9591892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian variation in ischemic threshold. A mechanism underlying the circadian variation in ischemic events.
    Quyyumi AA; Panza JA; Diodati JG; Lakatos E; Epstein SE
    Circulation; 1992 Jul; 86(1):22-8. PubMed ID: 1617775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amlodipine in post-infarction angina.
    Taylor SH
    Cardiology; 1992; 80 Suppl 1():26-30. PubMed ID: 1534712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Felodipine and amlodipine in stable angina pectoris: results of a randomized double-blind crossover trial.
    Koenig W; Höher M
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):520-4. PubMed ID: 9156363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia.
    Glasser SP; Frishman W; White WB; Stone P; Johnson MF
    Clin Cardiol; 2000 Jul; 23(7):524-9. PubMed ID: 10894441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the sympathetic nervous system in the pathogenesis of chronic stable angina. Implications for the mechanism of action of beta-blockers.
    Chierchia S; Muiesan L; Davies A; Balasubramian V; Gerosa S; Raftery EB
    Circulation; 1990 Sep; 82(3 Suppl):II71-81. PubMed ID: 1975525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN).
    van der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
    Angiology; 1999 Jun; 50(6):447-54. PubMed ID: 10378820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-Ischemia Program in Europe (CAPE Trial).
    Deanfield JE; Detry JM; Lichtlen PR; Magnani B; Sellier P; Thaulow E
    J Am Coll Cardiol; 1994 Nov; 24(6):1460-7. PubMed ID: 7930276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of the calcium channel blocker pranidipine on exercise-induced angina.
    Nishinaka Y; Yokota M; Watanabe M; Sobue T; Iwase M; Ukai M; Ando A; Nagata K; Saito H
    Int J Clin Pharmacol Ther; 1994 Oct; 32(10):542-9. PubMed ID: 7834162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian variation in ischemic threshold in patients with stable angina: relation to plasma endothelin-1.
    Li JJ; Huang CX; Fang CH; Chen F; Jiang H; Tang QZ; Li GS
    Angiology; 2002; 53(4):409-13. PubMed ID: 12143945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amlodipine versus diltiazem CR in the reduction of the total ischemic burden: the Circadian Anti-Ischemia Program in Europe (CAPE) II trial--clinical rationale and methodology.
    Deanfield JE
    Cardiovasc Drugs Ther; 1998 Oct; 12 Suppl 3():239-42. PubMed ID: 9800053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary vascular reactivity and calcium antagonist therapy in patients with angina.
    Perondi R; Saino A; Zanchetti A; Mancia G
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S30-6. PubMed ID: 7603075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting and postprandial ischemic threshold in patients with unstable angina with and without postprandial angina at rest.
    Figueras J; Domingo E
    Am Heart J; 1998 Aug; 136(2):252-8. PubMed ID: 9704686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early morning reduction in ischemic threshold in patients with unstable angina and significant coronary disease.
    Figueras J; Lidón RM
    Circulation; 1995 Oct; 92(7):1737-42. PubMed ID: 7671355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian variation of ischemic threshold in patients with chronic stable angina.
    Kishida H; Fukuma N; Saito T
    Int J Cardiol; 1992 Apr; 35(1):65-70. PubMed ID: 1563881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
    Klein W; Mitrovic V; Neuss H; Schlepper M; Cocco G; Prager G; Fitscha P; Meisner W
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S50-2. PubMed ID: 16296710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
    Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
    Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.